SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-010569
Filing Date
2022-07-07
Accepted
2022-07-07 15:39:38
Documents
13
Period of Report
2022-07-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220706x8k.htm   iXBRL 8-K 39043
2 EX-3.1 tmb-20220706xex3d1.htm EX-3.1 6190
  Complete submission text file 0001558370-22-010569.txt   171346

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20220706.xsd EX-101.SCH 3059
4 EX-101.LAB tmb-20220706_lab.xml EX-101.LAB 16674
5 EX-101.PRE tmb-20220706_pre.xml EX-101.PRE 10823
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220706x8k_htm.xml XML 4992
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 221071598
SIC: 2834 Pharmaceutical Preparations